RG-4733

DB11870InvestigationalSmall molecule

Ro4929097 has been used in trials studying the treatment of Sarcoma, LYMPHOMA, Neoplasms, Wilm's Tumor, and OSTEOSARCOMA, among others.

Chemical structure of RG-4733
Formula / weight
C22H20F5N3O3 · 469.412 g/mol (avg)
Code names
RO-4929097

Resolves to

Compound
UNIIKK8645V7LECAS847925-91-1ChEBI86474PubChem49867930
Structure
InChIKeyOJPLJFIFUQPSJR-INIZCTEOSA-NSMILESCC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C2=CC=CC=C2NC1=O
Targets
P49768PSEN1Q92542NCSTNQ9NZ42PSENENQ8WW43APH1BQ96BI3APH1A

What you can answer from here — as of January 29, 2025

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
35Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with RG-4733, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In